
|Articles|June 29, 2012
Schizophrenia Pharmacotherapy: What Role for Perphenazine? (Video 1:39 minutes)
Author(s)Peter F. Buckley, MD
In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.
Advertisement
In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.
Perphenazine was used in the CATIE study. Here, Dr. Peter Buckley addresses:
• The current role of perphenazine in the management of schizophrenia.
• The drug’s association with weight gain.
• The metabolic side effect profile of perphenazine.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap
2
Addressing Co-Occurring ADHD and Autism, With Lauren Kenworthy, PhD
3
January 2026 in Review: Updates on the Psychiatric Treatment Pipeline
4
The Psychopharmacology of Personality Disorders
5







